Consolidated Statements of Operations - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Revenues:
Earned premiums	$ 2,671,931	$ 1,800,933	$ 1,431,550
Other	31,630	22,697	2,609
Total revenues	2,703,561	1,823,630	1,434,159
Expenses:
Medical expenses	2,406,870	1,622,600	1,249,879
Selling, general, and administrative expenses	371,374	307,433	295,646
Depreciation and amortization	26,872	21,414	17,273
Total expenses	2,805,116	1,951,447	1,562,798
Loss from operations	(101,555)	(127,817)	(128,639)
Other expenses:
Interest expense	23,547	21,231	18,289
Other (income) expenses, net	(72)	(853)	176
Loss on extinguishment of debt	3,020	0	2,196
Total other expenses	26,495	20,378	20,661
Loss before income taxes	(128,050)	(148,195)	(149,300)
Net income tax expense (benefit)	21	(22)	339
Net loss	(128,071)	(148,173)	(149,639)
Less: Net loss attributable to noncontrolling interest	36	156	92
Net loss attributable to Alignment Healthcare, Inc.	$ (128,035)	$ (148,017)	$ (149,547)
Total weighted-average common shares outstanding - basic (in shares)	190,793,552	186,214,784	181,212,757
Total weighted-average common shares outstanding - diluted (in shares)	190,793,552	186,214,784	181,212,757
Net loss per share attributable to Alignment Healthcare, Inc. - basic (in dollars per share)	$ (0.67)	$ (0.79)	$ (0.83)
Net loss per share attributable to Alignment Healthcare, Inc. - diluted (in dollars per share)	$ (0.67)	$ (0.79)	$ (0.83)